NCK Pharma » Sobi

Saudi Food and Drug Administration (SFDA) has approved Swedish Orphan Biovitrum AB (Sobi)’s Orfadin (nitisinone)

Posted on18 May 2017

Tagsbiotech companies in the Middle East, Middle East Pharma market, nitisinone, Sanofi to expand its generic portfolio in Middle East with acquisition of significant stake in Globalpharma, Saudi Food and Drug Administration, SFDA, Sobi, Swedish Orphan Biovitrum AB

Comments0

Saudi Food and Drug Administration (SFDA) has approved Swedish Orphan Biovitrum AB (Sobi)’s Orfadin (nitisinone) capsules in all strengths (2 mg, 5...

Sobi

Saudi Food and Drug Administration (SFDA) has approved Swedish Orphan Biovitrum AB (Sobi)’s Orfadin (nitisinone)

Our Popular Courses

Recent Articles

Course Category

Certification Courses

Corporate Training

Your form has been submitted

Server Side Error

Error